Literature DB >> 18981990

Inhaled insulin--what went wrong.

Joanna Mitri1, Anastassios G Pittas.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18981990      PMCID: PMC4042087          DOI: 10.1038/ncpendmet1007

Source DB:  PubMed          Journal:  Nat Clin Pract Endocrinol Metab        ISSN: 1745-8366


× No keyword cloud information.
  4 in total

1.  Ten lessons for evidence-based technology assessment.

Authors:  J M Eisenberg
Journal:  JAMA       Date:  1999-11-17       Impact factor: 56.272

2.  Availability of inhaled insulin promotes greater perceived acceptance of insulin therapy in patients with type 2 diabetes.

Authors:  Nick Freemantle; Lawrence Blonde; Didier Duhot; Marcus Hompesch; Robert Eggertsen; F D Richard Hobbs; Luc Martinez; Stuart Ross; Björn Bolinder; Elmar Stridde
Journal:  Diabetes Care       Date:  2005-02       Impact factor: 19.112

3.  An assessment of eligibility for inhaled insulin (Exubera): the Fremantle Diabetes Study.

Authors:  Timothy M E Davis; Wendy A Davis
Journal:  Diabetes Care       Date:  2007-02       Impact factor: 19.112

4.  Meta-analysis: efficacy and safety of inhaled insulin therapy in adults with diabetes mellitus.

Authors:  Lisa Ceglia; Joseph Lau; Anastassios G Pittas
Journal:  Ann Intern Med       Date:  2006-11-07       Impact factor: 25.391

  4 in total
  5 in total

Review 1.  Non-invasive delivery strategies for biologics.

Authors:  Aaron C Anselmo; Yatin Gokarn; Samir Mitragotri
Journal:  Nat Rev Drug Discov       Date:  2018-11-30       Impact factor: 84.694

Review 2.  Inhaled aerosolized insulin: a "topical" anti-inflammatory treatment for acute lung injury and respiratory distress syndrome?

Authors:  Haim Shapiro; Ilya Kagan; Michal Shalita-Chesner; Joelle Singer; Pierre Singer
Journal:  Inflammation       Date:  2010-10       Impact factor: 4.092

Review 3.  Battle of GLP-1 delivery technologies.

Authors:  Minzhi Yu; Mason M Benjamin; Santhanakrishnan Srinivasan; Emily E Morin; Ekaterina I Shishatskaya; Steven P Schwendeman; Anna Schwendeman
Journal:  Adv Drug Deliv Rev       Date:  2018-07-21       Impact factor: 15.470

Review 4.  Intranasal drug delivery: opportunities and toxicologic challenges during drug development.

Authors:  Lea-Adriana Keller; Olivia Merkel; Andreas Popp
Journal:  Drug Deliv Transl Res       Date:  2021-01-25       Impact factor: 4.617

Review 5.  A Comprehensive Review of the Evolution of Insulin Development and Its Delivery Method.

Authors:  Vaisnevee Sugumar; Kuan Ping Ang; Ahmed F Alshanon; Gautam Sethi; Phelim Voon Chen Yong; Chung Yeng Looi; Won Fen Wong
Journal:  Pharmaceutics       Date:  2022-07-04       Impact factor: 6.525

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.